Dr. Vinay Prasad returning to FDA weeks after leaving role
Dr. Vinay Prasad will return to the Food and Drug Administration after being forced out two weeks ago, resuming his role overseeing vaccine, gene editing and blood product regulation, according to an HHS spokesperson.
"At the FDA’s request, Dr. Vinay Prasad is resuming leadership of the Center for Biologics Evaluation and Research,” a Health and Human Services spokesperson said. “Neither the White House nor HHS will allow the fake news media to distract from the critical work the FDA is carrying out under the Trump administration."
Prasad came under fire recently over his handling of a gene therapy that had been approved by the FDA and which he banned from being used and then reversed course under pressure from the company that makes it and advocates for its use.
A conservative backed campaign led by Laura Loomer and Rick Santorum also criticized his past political and scientific positions.
He left the FDA saying he didn’t want to be a distraction two weeks ago.
-ABC News’ Eric Strauss







